Dancann Pharma A/S DAN.F Stock
Dancann Pharma A/S Price Chart
Dancann Pharma A/S DAN.F Financial and Trading Overview
| Dancann Pharma A/S stock price | 0.0028 EUR |
| Previous Close | 0.03 EUR |
| Open | 0.03 EUR |
| Bid | 0.03 EUR x N/A |
| Ask | 0.05 EUR x N/A |
| Day's Range | 0.03 - 0.03 EUR |
| 52 Week Range | 0.03 - 0.37 EUR |
| Volume | 100 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 2.07M EUR |
| Beta (5Y Monthly) | 2.2752 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
DAN.F Valuation Measures
| Enterprise Value | -3407986 EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.3141839 |
| Price/Book (mrq) | 0.02912514 |
| Enterprise Value/Revenue | -0.518 |
| Enterprise Value/EBITDA | 0.225 |
Trading Information
Dancann Pharma A/S Stock Price History
| Beta (5Y Monthly) | 2.2752 |
| 52-Week Change | -89.82% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.37 EUR |
| 52 Week Low | 0.03 EUR |
| 50-Day Moving Average | 0.05 EUR |
| 200-Day Moving Average | 0.12 EUR |
DAN.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 67.15M |
| Float | 55.92M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -249.65% |
| Operating Margin (ttm) | -260.045% |
| Gross Margin | -90.46% |
| EBITDA Margin | -230.79% |
Management Effectiveness
| Return on Assets (ttm) | -15.040% |
| Return on Equity (ttm) | -27.87% |
Income Statement
| Revenue (ttm) | 6.58M EUR |
| Revenue Per Share (ttm) | 0.1 EUR |
| Quarterly Revenue Growth (yoy) | -37.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | -15175000 EUR |
| Net Income Avi to Common (ttm) | -16415000 EUR |
| Diluted EPS (ttm) | -0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.69M EUR |
| Total Cash Per Share (mrq) | 0.09 EUR |
| Total Debt (mrq) | 0 EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.967 |
| Book Value Per Share (mrq) | 0.903 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -11062000 EUR |
| Levered Free Cash Flow (ttm) | -15134875 EUR |
Profile of Dancann Pharma A/S
| Country | Germany |
| State | N/A |
| City | Ansager |
| Address | Rugvænget 5 |
| ZIP | 6823 |
| Phone | 45 69 16 03 93 |
| Website | https://www.dancann.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 10 |
Dancann Pharma A/S, a biopharmaceutical company, focuses on discovering, developing, manufacturing, and commercializing cannabinoid therapeutics in various disease areas. The company produces and distributes prescription and over-the-counter cannabinoid-based pharmaceuticals primarily focused on pain patients. Dancann Pharma A/S was incorporated in 2018 and is based in Ansager, Denmark.
Q&A For Dancann Pharma A/S Stock
What is a current DAN.F stock price?
Dancann Pharma A/S DAN.F stock price today per share is 0.0028 EUR.
How to purchase Dancann Pharma A/S stock?
You can buy DAN.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Dancann Pharma A/S?
The stock symbol or ticker of Dancann Pharma A/S is DAN.F.
Which industry does the Dancann Pharma A/S company belong to?
The Dancann Pharma A/S industry is Drug Manufacturers-Specialty & Generic.
How many shares does Dancann Pharma A/S have in circulation?
The max supply of Dancann Pharma A/S shares is 223.37M.
What is Dancann Pharma A/S Price to Earnings Ratio (PE Ratio)?
Dancann Pharma A/S PE Ratio is now.
What was Dancann Pharma A/S earnings per share over the trailing 12 months (TTM)?
Dancann Pharma A/S EPS is 0 EUR over the trailing 12 months.
Which sector does the Dancann Pharma A/S company belong to?
The Dancann Pharma A/S sector is Healthcare.